RLMD
Relmada Therapeutics
$3.35
+$0.14 (+4.36%)Oct 28, 2026
Key metrics
The numbers that frame RLMD today
- Market cap
- $357.34M
- ROIC
- -49%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.15
- 52wk High
- $8.00
Growth
Revenue and earnings trend for RLMD
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about RLMD
Is Relmada Therapeutics a good buy?
No. Relmada Therapeutics has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Relmada Therapeutics is selling at a very high price.
What is the market capitalization of RLMD?
Relmada Therapeutics's market capitalization is $357.34M.
What is the 52-week high for RLMD stock?
The 52-week high for Relmada Therapeutics is $8.00. The current close of $3.35 is 58.1% below that high.
What is the 52-week low for RLMD stock?
The 52-week low for Relmada Therapeutics is $2.15. The current close of $3.35 is 55.8% above that low.
Does RLMD stock pay dividends?
Relmada Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for RLMD?
Relmada Therapeutics's Debt / Equity ratio is 0.